[go: up one dir, main page]

PT1121349E - Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta - Google Patents

Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta

Info

Publication number
PT1121349E
PT1121349E PT99947450T PT99947450T PT1121349E PT 1121349 E PT1121349 E PT 1121349E PT 99947450 T PT99947450 T PT 99947450T PT 99947450 T PT99947450 T PT 99947450T PT 1121349 E PT1121349 E PT 1121349E
Authority
PT
Portugal
Prior art keywords
tiadiazolsulfonamides
interleucin
replaced
beta inhibitors
inhibitors
Prior art date
Application number
PT99947450T
Other languages
English (en)
Inventor
Werner Thorwart
Klaus-Ulrich Weithmann
Swen Holder
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT1121349E publication Critical patent/PT1121349E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT99947450T 1998-10-16 1999-10-02 Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta PT1121349E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19847823A DE19847823A1 (de) 1998-10-16 1998-10-16 Substituierte Thiadiazolsulfonamide

Publications (1)

Publication Number Publication Date
PT1121349E true PT1121349E (pt) 2004-08-31

Family

ID=7884736

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99947450T PT1121349E (pt) 1998-10-16 1999-10-02 Tiadiazolsulfonamidas substituidas como inibidores de interleucina-1-beta

Country Status (11)

Country Link
US (2) US6218412B1 (pt)
EP (1) EP1121349B1 (pt)
JP (1) JP4733270B2 (pt)
AR (1) AR023909A1 (pt)
AT (1) ATE263158T1 (pt)
AU (1) AU6088799A (pt)
DE (2) DE19847823A1 (pt)
DK (1) DK1121349T3 (pt)
ES (1) ES2214885T3 (pt)
PT (1) PT1121349E (pt)
WO (1) WO2000023430A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) * 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7851418B2 (en) * 2005-06-03 2010-12-14 Exxonmobil Research And Engineering Company Ashless detergents and formulated lubricating oil containing same
WO2009021052A1 (en) * 2007-08-06 2009-02-12 University Of Kentucky Research Foundation Polypeptides, systems, and methods useful for detecting glucose
EP2628734A4 (en) * 2010-10-15 2014-04-23 Federalnoe G Bydzhetnoe Uchrezhdenie Nauki Inst Fiziol Aktivnikh Veschestv Rossiiskoi Akademii Nauk DERIVATIVES OF 5-AMINO - [1,2,4] THIADIAZOLE
WO2013173672A1 (en) * 2012-05-18 2013-11-21 Array Biopharma Inc. Method for the preparation of thiadiazoles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985450A (en) 1987-01-29 1991-01-15 Tegeler John J Arylthiadiazolylsulfonamides and derivatives
US4758578A (en) * 1987-01-29 1988-07-19 Hoechst Roussel Pharmaceuticals, Inc. Arylthiadiazolylsulfonamides, pharmaceutical compositions and use
US4873239A (en) 1987-01-29 1989-10-10 Hoechst-Roussel Pharmaceuticals, Inc. Arylthiadiazolylsulfonamides and derivatives
ES2124800T3 (es) 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
WO1997016442A1 (en) * 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
JPH09235276A (ja) * 1995-12-27 1997-09-09 Takeda Chem Ind Ltd オキサゾール誘導体、その製造法および用途
WO1997024339A1 (fr) * 1995-12-27 1997-07-10 Ono Pharmaceutical Co., Ltd. Derives de tetrazole et medicaments les contenant a titre d'ingredients actifs
HUP9903330A2 (hu) * 1996-11-19 2000-03-28 Amgen Inc. Gyulladásgátló hatású, aril- és heteroaril csoporttal szubsztituált kondenzált pirrolszármazékok, valamint ezeket tartalmazó gyógyászati készítmények

Also Published As

Publication number Publication date
ATE263158T1 (de) 2004-04-15
DE19847823A1 (de) 2000-04-20
DK1121349T3 (da) 2004-07-12
JP2002527510A (ja) 2002-08-27
WO2000023430A1 (de) 2000-04-27
US20010039350A1 (en) 2001-11-08
EP1121349A1 (de) 2001-08-08
US6218412B1 (en) 2001-04-17
AU6088799A (en) 2000-05-08
JP4733270B2 (ja) 2011-07-27
ES2214885T3 (es) 2004-09-16
US6503934B2 (en) 2003-01-07
AR023909A1 (es) 2002-09-04
EP1121349B1 (de) 2004-03-31
DE59909049D1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
CU23063A3 (es) Imidazotriazinonas 2-fenil sustituidas como inhibidores de fosfodiesterasas
PT1084114E (pt) Derivados isotiazole uteis como agentes anticancerigenos
PT1181017E (pt) Inibidores de metaloproteases
PT1114033E (pt) 4-carboxiamino-2-metil-1,2,3,4-tetra-hidroquinolinas como inibidores de cetp
PT1185529E (pt) Pirazolobenzodiazepinas como inibidores de cdk2
CU23082A3 (es) 4-carboxiamino-2-subsituidos-1,2,3,4- tetrahidroquinolas como inhibidores cetp
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
AR028576A1 (es) Derivados de b-carbolina utiles como inhibidores de fosfodiesterasa
PT1105375E (pt) Trifluorometilpirrolecarboxamidas uteis como fungicidas
PT946512E (pt) Derivados de 6-fenilpiridil-2-amina uteis como inibidores de nos
NO20016115D0 (no) Substituerte heterocykelkondenserte gamma-karboliner
PT1194404E (pt) Inibidores de aspartil-protease
PT1001934E (pt) Compostos de indole como inibidores de cox-2
AR028575A1 (es) Derivados de pirrolopiridinona utiles como inhibidores de fosfodiesterasa
DE60036430D1 (de) Werkzeughalter
PT1089996E (pt) Metanossulfonato de paroxetina
PT1212320E (pt) Fenilpiperazinas como inibidores de reabsorcao de serotonina
DE69935402D1 (de) Saugfähiger Gegenstand
DE69920073D1 (de) kinderschutzhöschen
PT1097127E (pt) Derivados de diacil-hidrazina como inibidores da integrina
PT1218009E (pt) Grandulos de quetiapina
DE69902762D1 (de) Riser-spannanordnung
PT1023268E (pt) Isoquinolinas como inibidores de uroquinase
DZ3244A1 (fr) Inhibiteurs de 8-arylquinoline phosphodiesterase-4 substituee
ES1044448Y (es) Auto-aplicador de vendaje